Molecular Partners AG
SIX:MOLN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Downer EDI Ltd
NZX:DOW
|
AU |
|
Restaurant Brands Asia Ltd
NSE:RBA
|
IN |
|
Best Linking Group Holdings Ltd
HKEX:8617
|
HK |
|
Multiconsult ASA
OSE:MULTI
|
NO |
|
G
|
Get Nice Financial Group Ltd
HKEX:1469
|
HK |
Molecular Partners AG
Total Receivables
Molecular Partners AG
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Molecular Partners AG
SIX:MOLN
|
Total Receivables
CHf1.8m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Total Receivables
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Total Receivables
CHf63.3m
|
CAGR 3-Years
1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
30%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Total Receivables
CHf42.3m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Total Receivables
CHf40.2m
|
CAGR 3-Years
123%
|
CAGR 5-Years
96%
|
CAGR 10-Years
N/A
|
|
|
Relief Therapeutics Holding SA
SIX:RLF
|
Total Receivables
CHf1.5m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Molecular Partners AG
Glance View
Molecular Partners AG engages in the development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. The company is headquartered in Schlieren, Zuerich and currently employs 163 full-time employees. The company went IPO on 2014-10-22. The firm has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
See Also
What is Molecular Partners AG's Total Receivables?
Total Receivables
1.8m
CHF
Based on the financial report for Dec 31, 2025, Molecular Partners AG's Total Receivables amounts to 1.8m CHF.
What is Molecular Partners AG's Total Receivables growth rate?
Total Receivables CAGR 5Y
-8%
Over the last year, the Total Receivables growth was -21%. The average annual Total Receivables growth rates for Molecular Partners AG have been 22% over the past three years , -8% over the past five years .
